MLchartDataset catalogue

anti-GD2 monoclonal antibody MORAb-028

Term · Oncology and biomedicine · MLC-T-ONC-010688

A human IgM monoclonal antibody directed against disialoganglioside GD2 with potential immunomodulating activity. Upon administration, anti-GD2 monoclonal antibody MORAb-028 may stimulate the immune system to exert a complement-mediated cytotoxic response against GD2-expressing tumor cells. The glycosphingolipid GD2 is a tumor associated antigen (TAA) overexpressed on the surface of many cancer cells.

Table 1. Record
IdentifierMLC-T-ONC-010688
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-010688",
  "term": "anti-GD2 monoclonal antibody MORAb-028",
  "field": "Oncology and biomedicine",
  "definition": "A human IgM monoclonal antibody directed against disialoganglioside GD2 with potential immunomodulating activity. Upon administration, anti-GD2 monoclonal antibody MORAb-028 may stimulate the immune system to exert a complement-mediated cytotoxic response against GD2-expressing tumor cells. The glycosphingolipid GD2 is a tumor associated antigen (TAA) overexpressed on the surface of many cancer cells.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-gd2-monoclonal-antibody-morab-028/"
}

Record 1,791 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.